Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments

Introduction: Primary immune thrombocytopenia is a rare autoimmune disease characterised by a decreased platelet count resulting in an increased risk of bleeding events and even life-threatening haemorrhages. Thrombopoietin receptor agonists (TPO-RAs) are the standard of care second-line therapy for...

Descripción completa

Detalles Bibliográficos
Autores principales: Aiello, Andrea, Mariano, Elisa Elena, Prada, Mariangela, Teruzzi, Cristina, Martone, Nicoletta, Capri, Stefano, Carli, Giuseppe, Siragusa, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316730/
https://www.ncbi.nlm.nih.gov/pubmed/37405228
http://dx.doi.org/10.1080/20016689.2023.2230663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316730/
https://www.ncbi.nlm.nih.gov/pubmed/37405228
http://dx.doi.org/10.1080/20016689.2023.2230663

Ejemplares similares